海泰新光：9月22日召开董事会会议

Core Viewpoint - Haitai Xinguang announced the convening of its fourth board meeting to discuss the re-election of the audit committee members, indicating ongoing governance activities within the company [1]. Company Summary - Haitai Xinguang's revenue composition for the year 2024 is as follows: 77.94% from medical device manufacturing, 21.55% from the optical medical industry, and 0.51% from other businesses [1]. - As of the report, Haitai Xinguang has a market capitalization of 5.7 billion yuan [1].